VAPOTHERM INC Income Statement

Ask AI

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021	FY2020 12 months to Dec 31, 2020	FY2019 12 months to Dec 31, 2019
Net revenue
Cost of revenue
Gross profit
Operating expenses
Research and development
Sales and marketing
General and administrative
Impairment of goodwill
Impairment of long-lived and intangible assets
Loss on disposal of property and equipment
Total operating expenses
Loss from operations
Other (expense) income
Interest expense
Interest income
Other income
Gain on litigation settlement
Foreign currency loss
Loss on extinguishment of debt
Other

Net loss before income taxes
Provision for income taxes
Net loss
Net loss attributable to common stockholders
Other comprehensive income (loss):
Foreign currency translation adjustments
Total other comprehensive income (loss)
Total comprehensive loss
Net loss per share - basic and diluted
Weighted-average number of shares used in calculating net loss per share, basic and diluted
Net loss per share - basic
Net loss per share - diluted
Weighted-average number of shares used in calculating net loss per share, basic
Weighted-average number of shares used in calculating net loss per share, diluted

Comments